Evaluation of The Iron Effect on Thyroid Function in Wome
Phase 3
Recruiting
- Conditions
- Other hypothyroidism.Other hypothyroidism
- Registration Number
- IRCT20151114025031N7
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 94
Inclusion Criteria
Hypothyroidism with TSH in the range of 0.05 to 5 mu/l, which with the use of levothyroxine for at least 6 months or more remains in this range.
Female
Between 20 to 70 years old
Exclusion Criteria
Pregnancy that occurs during the study
Breastfeeding that occurs during the study
Chronic diseases, such as liver and kidney disease, that occurs during the study
Gi intolerance to iron tablets
Patients with thyroid cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method T3 Level. Timepoint: Before and two months after intervention. Method of measurement: enzyme-linked fluorescence assay (ELFA).;T4 Level. Timepoint: Before and two months after intervention. Method of measurement: enzyme-linked fluorescence assay (ELFA).;TSH Level. Timepoint: Before and two months after intervention. Method of measurement: enzyme-linked fluorescence assay (ELFA).;Ferritin Level. Timepoint: Before and two months after intervention. Method of measurement: enzyme-linked fluorescence assay (ELFA).;Hemoglobin Level. Timepoint: Before and two months after intervention. Method of measurement: enzyme-linked fluorescence assay (ELFA).;Serum Iron Level. Timepoint: Before and two months after intervention. Method of measurement: enzyme-linked fluorescence assay (ELFA).
- Secondary Outcome Measures
Name Time Method